172@29@17@144!~!172@29@0@53!~!|news|business|earnings|alembic-pharma-standalone-december-2019-net-sales-at-rs-1052-36-crore-up-16-32-y-o-y-4848181.html!~!news|moneycontrol|com!~!|controller|infinite_scroll_article.php!~!is_mobile=false
Moneycontrol
Subscribe to PRO at just Rs.33 per month. Use code SUPERPRO
Last Updated : Jan 23, 2020 10:49 AM IST | Source: Moneycontrol.com

Alembic Pharma Standalone December 2019 Net Sales at Rs 1,052.36 crore, up 16.32% Y-o-Y

 
 
live
  • bselive
  • nselive
Volume
Todays L/H
More

Reported Standalone quarterly numbers for Alembic Pharmaceuticals are:

Net Sales at Rs 1,052.36 crore in December 2019 up 16.32% from Rs. 904.72 crore in December 2018.

Quarterly Net Profit at Rs. 231.19 crore in December 2019 up 66.91% from Rs. 138.51 crore in December 2018.

Close

EBITDA stands at Rs. 321.40 crore in December 2019 up 54.22% from Rs. 208.41 crore in December 2018.

Alembic Pharma EPS has increased to Rs. 12.26 in December 2019 from Rs. 7.35 in December 2018.

Alembic Pharma shares closed at 590.20 on January 22, 2020 (NSE) and has given 14.69% returns over the last 6 months and 0.00% over the last 12 months.

Alembic Pharmaceuticals
Standalone Quarterly Resultsin Rs. Cr.
Dec'19Sep'19Dec'18
Net Sales/Income from operations1,052.361,134.90904.72
Other Operating Income------
Total Income From Operations1,052.361,134.90904.72
EXPENDITURE
Consumption of Raw Materials233.05239.77201.74
Purchase of Traded Goods50.0478.0862.49
Increase/Decrease in Stocks1.81-40.879.61
Power & Fuel------
Employees Cost204.62201.79183.96
Depreciation34.3132.5126.56
Excise Duty------
Admin. And Selling Expenses------
R & D Expenses------
Provisions And Contingencies------
Exp. Capitalised------
Other Expenses241.73295.40241.87
P/L Before Other Inc. , Int., Excpt. Items & Tax286.80328.22178.49
Other Income0.290.283.36
P/L Before Int., Excpt. Items & Tax287.09328.50181.85
Interest6.936.634.62
P/L Before Exceptional Items & Tax280.16321.87177.23
Exceptional Items------
P/L Before Tax280.16321.87177.23
Tax48.9753.1838.72
P/L After Tax from Ordinary Activities231.19268.69138.51
Prior Year Adjustments------
Extra Ordinary Items------
Net Profit/(Loss) For the Period231.19268.69138.51
Equity Share Capital37.7037.7037.70
Reserves Excluding Revaluation Reserves------
Equity Dividend Rate (%)------
EPS Before Extra Ordinary
Basic EPS12.2614.257.35
Diluted EPS12.2614.257.35
EPS After Extra Ordinary
Basic EPS12.2614.257.35
Diluted EPS12.2614.257.35
Public Share Holding
No Of Shares (Crores)------
Share Holding (%)------
Promoters and Promoter Group Shareholding
a) Pledged/Encumbered
- Number of shares (Crores)------
- Per. of shares (as a % of the total sh. of prom. and promoter group)------
- Per. of shares (as a % of the total Share Cap. of the company)------
b) Non-encumbered
- Number of shares (Crores)------
- Per. of shares (as a % of the total sh. of prom. and promoter group)------
- Per. of shares (as a % of the total Share Cap. of the company)------
Source : Dion Global Solutions Limited

First Published on Jan 23, 2020 10:40 am
Sections